When the calretinin positive cases and calretinin negative cases were compared, there were no significant differences: although calretinin expression was more common in females (F:M=2:1); the mean age, tumor location, the median tumor size, and the rates of lymph node and distant metastases were similar. The gene discussed is CALB2; the disease is neoplasm.